Viewing data from:

CLONIDINE

ANDA

CLONIDINE | A079090 | DR REDDYS LABORATORIES SA

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CATAPRES-TTS-1(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$12.72

per ea

Lowest NADAC/Unit

$6.76

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
75907002548CLONIDINE 0.3 MG/DAY PATCH	$12.72	EA	Generic	—	2026-06-17
75907002448CLONIDINE 0.2 MG/DAY PATCH	$9.59	EA	Generic	—	2026-06-17
75907002348CLONIDINE 0.1 MG/DAY PATCH	$6.76	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$15.62

Highest Price

$29.96

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
75907-0023-48CLONIDINE 0.1MG/24HRS PATCH	$15.62	FSS	Dr. Reddys Laboratories	09/14/2026
75907-0024-48CLONIDINE 0.2MG/24HRS PATCH	$21.46	FSS	Dr. Reddys Laboratories	09/14/2026
75907-0025-48CLONIDINE 0.3MG/24HRS PATCH	$29.96	FSS	Dr. Reddys Laboratories	09/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLCLONIDINE HCL

DMF 44931982

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLCLONIDINE BASE

DMF 128661998

PCASCLONIDINE BASE

DMF 129641998

ZYDUS LIFESCIENCES LTDCLONIDINE

DMF 219352008

ALEMBIC PHARMACEUTICALS LTDCLONIDINE USP

DMF 284942014

CIPLA LTDInactiveCLONIDINE HCL

DMF 54461984

TEMMLER WERKE VEREINIGTE CHEMISCHE FABRIKENInactiveCLONIDINE HCL. 0.6MG. C.R. CAPSULES

DMF 58741985

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.1MG/24HR

0 patents0 exclusivities▴

SYSTEM;TRANSDERMAL | Approved: Aug 20, 2010

No patent or exclusivity listings for this strength.

#002 — 0.2MG/24HR

0 patents0 exclusivities▾

SYSTEM;TRANSDERMAL | Approved: Aug 20, 2010

#003 — 0.3MG/24HR

0 patents0 exclusivities▾

SYSTEM;TRANSDERMAL | Approved: Aug 20, 2010